NASDAQ

Telomir Pharmaceuticals, Inc. (TELO)

♥ 594 Thanks from members

Live price chart, market sentiment, and community perspectives for Telomir Pharmaceuticals, Inc. (NASDAQ: TELO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Telomir Pharmaceuticals ManagementLeadership: Chris Chapman (CEO)Holder: Institutional Life Science InvestorsHolder: Insider ShareholdersTelomere-targeting therapeuticsAge-related disease treatments#TELO stock#Telomir Pharmaceuticals#telomere extension#biotech startup#longevity therapeutics